Circulation. 2007;115:1948-1967
Published online before print March 21, 2007, doi: 10.1161/CIRCULATIONAHA.107.181946
Published online before print March 21, 2007, doi: 10.1161/CIRCULATIONAHA.107.181946
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:1948-1967.)
© 2007 American Heart Association, Inc.
AHA Scientific Statement |
Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents
A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia. The purpose of this statement is to examine new evidence on the association of lipid abnormalities with early atherosclerosis, discuss challenges with previous guidelines, and highlight results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterolemia. Recommendations are provided to guide decision-making with regard to patient selection, initiation, monitoring, and maintenance of drug therapy.
Key Words: AHA Scientific Statements • lipids • pediatrics • drugs • hypercholesterolemia
This article has been cited by other articles:
 |
|
 |
|
  J. M. Lee, A. Gebremariam, P. Card-Higginson, J. L. Shaw, J. W. Thompson, and M. M. Davis Poor Performance of Body Mass Index as a Marker for Hypercholesterolemia in Children and Adolescents Arch Pediatr Adolesc Med, August 1, 2009; 163(8): 716 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Marimuthu and B S Menon Acanthosis nigricans Arch. Dis. Child., June 1, 2009; 94(6): 477 - 477. [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Robinson Nutrition Evidence-Based Guidelines for Treating Hyperlipidemia in Children With Type 1 Diabetes: A Case Presentation The Diabetes Educator, May 1, 2009; 35(3): 408 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Liberman, J. E. Berger, and M. Lewis Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents Arch Pediatr Adolesc Med, April 1, 2009; 163(4): 357 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Barra, G Gaeta, S Cuomo, P Guarini, M C Foglia, G Capozzi, C Materazzi, and M Trevisan Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction Heart, April 1, 2009; 95(8): 642 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Magnussen, A. Venn, R. Thomson, M. Juonala, S. R. Srinivasan, J. S.A. Viikari, G. S. Berenson, T. Dwyer, and O. T. Raitakari The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J. Am. Coll. Cardiol., March 10, 2009; 53(10): 860 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Manlhiot, P. Larsson, R. C. Gurofsky, R. W. Smith, C. Fillingham, N. A. Clarizia, N. Chahal, J. T. Clarke, and B. W. McCrindle Spectrum and Management of Hypertriglyceridemia Among Children in Clinical Practice Pediatrics, February 1, 2009; 123(2): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 American Diabetes Association Standards of Medical Care in Diabetes--2009 Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Pasquali and J. S. Li Prevention of Future Cardiovascular Disease in High-Risk Pediatric Patients: A Role for Lipid Lowering Therapy? Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 131 - 133. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Cox, D. R. Halloran, S. M. Homan, S. Welliver, and D. E. Mager Trends in the Prevalence of Chronic Medication Use in Children: 2002-2005 Pediatrics, November 1, 2008; 122(5): e1053 - e1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van der Graaf, C. Cuffie-Jackson, M. N. Vissers, M. D. Trip, C. Gagne, G. Shi, E. Veltri, H. J. Avis, and J. J.P. Kastelein Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1421 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Daniels, F. R. Greer, and N. Stettler An Assessment of the New Lipid Screening Guidelines: In Reply Pediatrics, October 1, 2008; 122(4): 906 - 907. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Miller, C. Manlhiot, N. Chahal, G. Cullen-Dean, L. Bannister, and B. W. McCrindle Impact of Increasing Adiposity in Hyperlipidemic Children Clinical Pediatrics, September 1, 2008; 47(7): 679 - 684. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Daniels, F. R. Greer, and and the Committee on Nutrition Lipid Screening and Cardiovascular Health in Childhood Pediatrics, July 1, 2008; 122(1): 198 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Matyka Type 2 diabetes in childhood: epidemiological and clinical aspects Br. Med. Bull., June 1, 2008; 86(1): 59 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Palinski and C. Napoli Impaired Fetal Growth, Cardiovascular Disease, and the Need to Move on Circulation, January 22, 2008; 117(3): 341 - 343. [Full Text] [PDF]
|
|
|
|
|
|
J. Steinberger and A. S. Kelly Challenges of Existing Pediatric Dyslipidemia Guidelines: Call for Reappraisal Circulation, January 1, 2008; 117(1): 9 - 10. [Full Text] [PDF]
|
|
|
|
|
|
C. G. Magnussen, O. T. Raitakari, R. Thomson, M. Juonala, D. A. Patel, J. S.A. Viikari, J. Marniemi, S. R. Srinivasan, G. S. Berenson, T. Dwyer, et al. Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood: Evidence From the Childhood Determinants of Adult Health (CDAH) Study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation, January 1, 2008; 117(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Velasquez-Mieyer, C. P. Neira, R. Nieto, and P. A. Cowan Review: Obesity and cardiometabolic syndrome in children Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 61 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Hendry Statins May Benefit Kids With Recalcitrant Lipids DOC News, October 1, 2007; 4(10): 3 - 8. [Full Text]
|
|
|
|
|
|
E. A. Stein Statins and Children: Whom Do We Treat and When? Circulation, August 7, 2007; 116(6): 594 - 595. [Full Text] [PDF]
|
|
|
|
|
|
L. L. Hayman, J. C. Meininger, S. R. Daniels, B. W. McCrindle, L. Helden, J. Ross, B. A. Dennison, J. Steinberger, and C. L. Williams Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth: A Scientific Statement From the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism Circulation, July 17, 2007; 116(3): 344 - 357. [Full Text] [PDF]
|
|
|
|
|
|
US Preventive Services Task Force Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement Pediatrics, July 1, 2007; 120(1): e215 - e219. [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. McCrindle and for the Writing Group Summary of the American Heart Association's Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 982 - 985. [Full Text] [PDF]
|
|